Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2021

Open Access 01-12-2021 | Schizophrenia | Research article

Metacognitive training: a useful complement to community-based rehabilitation for schizophrenia patients in China

Authors: Qi Chen, Yueyun Sang, Lifang Ren, Jinping Wu, Yajun Chen, Menglei Zheng, Guolin Bian, Hanying Sun

Published in: BMC Psychiatry | Issue 1/2021

Login to get access

Abstract

Background

The traditional general practitioner-based model (community-based rehabilitation [CBR]) for Chinese schizophrenia patients lacks sufficient content, usefulness, and theoretical basis for rehabilitation. Based on previous research, we postulate that Metacognitive Training (MCT) is effective in the community for schizophrenic patients.

Method

A randomized controlled, assessor-blinded trial was conducted. A total of 124 schizophrenia patients were recruited from Ningbo China and were randomly assigned to an intervention or a control group. A general practitioner (GP) training plan was carried out before intervention. Intervention and control groups received two CBR follow-ups once a month, while the intervention group, received an additional eight once-a-in-week session of MCT. The Positive and Negative Syndrome Scale (PANSS), and the Psychotic Symptom Rating Scales (PSYRATS) were the primary outcome instruments, while the Quality of Life Scale (SQLS) was the secondary outcome instrument.

Results

In the post-treatment between-groups assessment, the patients in the intervention group showed significantly more reductions on PSYRATS delusions, PSYRATS total, PANSS P6, PANSS core delusions, PANSS positive, PANSS negative, PANSS general and PANSS total, and a significant improvement in SQLS psychosocial aspect.

Conclusions

The study provides preliminary evidence for the usefulness of MCT as a complementary measure for community-based rehabilitation of schizophrenia patients.

Trial registration

ISRCTN, ISRCTN17333276. Registered 09 August 2020 - Retrospectively registered.
Literature
1.
Karow A, Pajonk FG. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr Opin Psychiatry. 2006;19(6):637–41.PubMedCrossRef
2.
Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–53.PubMedCrossRef
3.
Chan KY, Zhao F, Meng S, et al. Prevalence of schizophrenia in China between 1990 and 2010. J Glob Health. 2015;5(1):10410.CrossRef
4.
Chang DF, Xu Y, Kleinman A, Kleinman J. Rehabilitation of Schizophrenia Patients in China; 2007. p. 27–50.
5.
Raja S, Boyce WF, Ramani S, Underhill C. Success indicators for integrating mental health interventions with community-based rehabilitation projects. Int J Rehabil Res. 2008;31(4):284–92.PubMedCrossRef
6.
Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China's huge and complex health-care reforms. Lancet. 2012;379(9818):833–42.PubMedCrossRef
7.
Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Fitzpatrick R, Jenkinson C. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42–6.PubMedCrossRef
8.
Phillips MR. Can China's new mental health law substantially reduce the burden of illness attributable to mental disorders? Lancet. 2013;381(9882):1964–6.PubMedCrossRef
9.
Wang XQ, Petrini M, Morisky DE. Comparison of the Quality of Life, Perceived Stigma and Medication Adherence of Chinese with Schizophrenia: A Follow-Up Study. Arch Psychiatr Nurs. 2016;30(1):41–6.PubMedCrossRef
10.
Xiong W, Phillips MR, Hu X, Wang R, Dai Q, Kleinman J, Kleinman A. Family-based intervention for schizophrenic patients in China. Brit J Psychiat. 1994;165(2):239–47.PubMedCrossRef
11.
Swanson JW, Borum R, Swartz MS, Monahan J. Psychotic symptoms and disorders and the risk of violent behaviour in the community. Crim Behav Ment Heal. 1996;6(4):309–29.CrossRef
12.
Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a review. Soc Psych Psych Epid. 2014;49(8):1179–89.CrossRef
13.
Falloon IR, Held T, Roncone R, Coverdale JH, Laidlaw TM. Optimal treatment strategies to enhance recovery from schizophrenia. Aust N Z J Psychiatry. 1998;32(1):43–9.PubMedCrossRef
14.
Moritz S, Vitzthum F, Randjbar S, Veckenstedt R, Woodward TS. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatr. 2010;23(6):561–9.CrossRef
15.
Moritz S, Veckenstedt R, Andreou C, et al. Sustained and “Sleeper” Effects of Group Metacognitive Training for Schizophrenia. Jama Psychiat. 2014;71(10):1103.CrossRef
16.
Moritz S, Veckenstedt R, Bohn F, et al. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr Res. 2013;151(1):61–9.PubMedCrossRef
17.
Lam KCK, Ho CPS, Wa JC, Chan SMY, Yam KKN, Yeung OSF, Wong WCH, Balzan RP. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders. Behav Res Ther. 2015;64:38–42.PubMedCrossRef
18.
Balzan RP, Delfabbro PH, Galletly CA, Woodward TS. Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme. Australian New Zealand J Psychiatry. 2014;48(12):1126–36.CrossRef
19.
Vitzthum FB, Veckenstedt R, Moritz S. Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms. Behav Cogn Psychoth. 2014;42(1):105–10.CrossRef
20.
Moritz S, Woodward TS. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr Opin Psychiatr. 2007;20(6):619–25.CrossRef
21.
Moritz S, Andreou C, Schneider BC, Wittekind CE, Menon M, Balzan RP, Woodward TS. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia. Clin Psychol Rev. 2014;34(4):358–66.PubMedCrossRef
22.
Briki M, Monnin J, Haffen E, et al. Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Schizophr Res. 2014;157(1–3):99–106.PubMedCrossRef
23.
Gaweda L, Krezolek M, Olbrys J, Turska A, Kokoszka A. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia. J Behav Ther Exp Psychiatry. 2015;48:98–104.PubMedCrossRef
24.
Moritz S, Kerstan A, Veckenstedt R, Randjbar S, Vitzthum F, Schmidt C, Heise M, Woodward TS. Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther. 2011;49(3):151–7.PubMedCrossRef
25.
Andreou C, Wittekind CE, Fieker M, Heitz U, Moritz S. Individualized metacognitive therapy for delusions: a randomized controlled rater-blind study. J Behav Ther Exp Psy. 2017;56:144.CrossRef
26.
Favrod J, Rexhaj S, Bardy S, Ferrari P, Hayoz C, Moritz S, Conus P, Bonsack C. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Eur Psychiat. 2014;29(5):275–81.CrossRef
27.
Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J. Metacognitive group training for forensic and dangerous non-forensic patients with schizophrenia: a randomised controlled feasibility trial. Criminal Behaviour Mental Health. 2014;24(5):345–57.PubMedCrossRef
28.
Liu YC, Tang CC, Hung TT, Tsai PC, Lin MF. The Efficacy of Metacognitive Training for Delusions in Patients With Schizophrenia: A Meta-Analysis of Randomized Controlled Trials Informs Evidence-Based Practice. Worldviews on Evidence-Based Nursing. 2018;15(2):130–9.PubMedCrossRef
29.
Eichner C, Berna F. Acceptance and efficacy of metacognitive training (MCT) on positive symptoms and delusions in patients with schizophrenia: a meta-analysis taking into account important moderators. Schizophrenia Bull. 2016;42(4):952–62.CrossRef
30.
Kumar D, Zia Ul Haq M, Dubey I, Dotivala KN, Veqar Siddiqui S, Prakash R, Abhishek P, Nizamie SH. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur J Psychotherapy Counselling 2010;12(2):149–158.
31.
Spaulding WD, Fleming SK, Reed D, Sullivan M, Storzbach D, Lam M. Cognitive Functioning in Schizophrenia: Implications for Psychiatric Rehabilitation. Schizophrenia Bull. 1999;25(2):275–89.CrossRef
32.
Awad AG, Voruganti LN. Quality of life and new antipsychotics in schizophrenia. Are patients better off? Int J Soc Psychiatry. 1999;45(4):268–75.PubMedCrossRef
33.
Alptekin K, Akvardar Y, Kivircik AB, Dumlu K, Isik D, Pirincci F, Yahssin S, Kitis A. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2):239–44.PubMedCrossRef
34.
Sibitz I, Amering M, Unger A, et al. The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. Eur Psychiatry. 2011;26(1):28–33.PubMedCrossRef
35.
Karow A, Pajonk FG, Reimer J, Hirdes F, Osterwald C, Naber D, Moritz S. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur Arch Psy Clin N. 2008;258(3):152–9.
36.
Xiang Y, Wang Y, Wang C, et al. Association of insight with sociodemographic and clinical factors, quality of life, and cognition in Chinese patients with schizophrenia. Compr Psychiat. 2012;53(2):140–4.PubMedCrossRef
37.
Lin H, Tang X, Shen P, Zhang D, Gao P. Using big data to improve cardiovascular care and outcomes in China: a protocol for the CHinese electronic health records research in Yinzhou (CHERRY) study. BMJ Open. 2018;8(2):e19698.CrossRef
38.
Association AP. Diagnostic and statistical manual of mental disorders (DSM-IV-TR); 1994.
39.
Kay SR, Abraham F, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull. 1987;2:2.
40.
Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL. Item response analysis of the Positive and Negative Syndrome Scale. Bmc Psychiatry. 2007;7:66.PubMedPubMedCentralCrossRef
41.
HADDOCK G, McCARRON J, TARRIER N, FARAGHER EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879–89.PubMedCrossRef
42.
Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The psychotic symptom rating scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89(1–3):119–22.PubMedCrossRef
43.
Cohen J. Statistical power ANALYSIS for the Behavioral sciences. J Am Stat Assoc. 1988;2nd(334):499–500.
44.
Walsh E, Gilvarry C, Samele C, et al. Predicting violence in schizophrenia: a prospective study. Schizophr Res. 2004;67(2–3):247–52.PubMedCrossRef
45.
Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G. Acting on persecutory delusions: the importance of safety seeking. Behav Res Ther. 2007;45(1):89–99.PubMedCrossRef
46.
Kunitoh N. From hospital to the community: the influence of deinstitutionalization on discharged long-stay psychiatric patients. Psychiat Clin Neuros. 2013;67(6):384–96.CrossRef
47.
Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, O'Callaghan E. Quality of life in schizophrenia: its relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Schizophr Res. 1996;18(2):238.CrossRef
48.
Moritz S, Woodward TS, Balzan R. Is metacognitive training for psychosis effective? Expert Rev Neurother. 2016;16(2):105–7.PubMedCrossRef
49.
Iemmi V, Kumar KS, Blanchet K, Gibson L, Kuper H. Community-based rehabilitation for people with physical and mental disabilities in low- and middle-income countries. Cochrane Db Syst Rev(Online). 2013(7).
50.
Kelly L. RealWorld evaluation: Working under budget, time, data, and political constraints (2nd ed.). Vol 49: Routledge; 2018:117–118.
51.
McCabe R, Roder-Wanner UU, Hoffmann K, Priebe S. Therapeutic relationships and quality of life: association of two subjective constructs in schizophrenia patients. Int J Soc Psychiatry. 1999;45(4):276–83.PubMedCrossRef
52.
Andreou C, Wittekind CE, Fieker M, Heitz U, Veckenstedt R, Bohn F, Moritz S. Individualized metacognitive therapy for delusions: A randomized controlled rater-blind study. J Behav Ther Exp Psychiatry. 2017;56:144–51.PubMedCrossRef
53.
Moritz S, Menon M, Andersen D, et al. Moderators of Symptomatic Outcome in Metacognitive Training for Psychosis (MCT). Who Benefits and Who Does Not? Cogn Ther Res. 2018;42:80–91.
Metadata
Title
Metacognitive training: a useful complement to community-based rehabilitation for schizophrenia patients in China
Authors
Qi Chen
Yueyun Sang
Lifang Ren
Jinping Wu
Yajun Chen
Menglei Zheng
Guolin Bian
Hanying Sun
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-021-03039-y

Other articles of this Issue 1/2021

BMC Psychiatry 1/2021 Go to the issue

Research article

The effect of counseling on fathers’ stress and anxiety during pregnancy: a randomized controlled clinical trial

Research

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder

Study protocol

Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: study protocol of a multicentre pragmatic randomized controlled trial

Study protocol

Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression

Research Article

Mathematical pattern of Kessler psychological distress distribution in the general population of the U.S. and Japan

Research article

Professional perspectives on providing recovery-oriented services in Taiwan: a qualitative study